Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis
Pulmonary fibrosis (PF) is a chronic interstitial lung disease characterized by structural damage to the lung parenchyma, excessive deposition of extracellular matrix (ECM), and irreversible decline in lung function. Current pharmacological treatments cannot effectively reverse fibrosis, highlightin...
Spremljeno u:
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2026-04-01
|
| Serija: | Frontiers in Medicine |
| Teme: | |
| Online pristup: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1817835/full |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|